John Kiely sold $380K of Amneal Pharmaceuticals (AMRX)

Executed May 12 2025, disclosed May 13 2025, 1 day later.

Value, as filed

$380K

50,000 sh × $7.59

Executed

May 12 2025

the trade date, as filed

Disclosed

May 13 2025

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JK John Kiely Director profile →

John Kiely (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Amneal Pharmaceuticals, Inc. (AMRX). The largest single filing was $882K of AMRX (50,000 sh × $17.64, as filed), executed Aug 13.

The name

AMRX Amneal Pharmaceuticals, Inc. AMRX · Healthcare · 32 filings in 24 months ticker →

Healthcare · Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, b…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by John Kiely in AMRX

AMRXSALE Amneal Pharmaceuticals, Inc. $882K
50,000 sh × $17.64
Exec Aug 13
Filed Aug 14 · 4:29 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $295K
32,000 sh × $9.23
Exec Aug 27 2025
Filed Aug 28 2025 · 5:30 PM ET AMRXSALE Amneal Pharmaceuticals, Inc. $143K
17,058 sh × $8.38
Exec Nov 22 2024
Filed Nov 26 2024 · 5:30 PM ET